Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-11
DOI
10.3389/fonc.2021.537140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma
- (2020) Bolin Wang et al. MEDICINE
- Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis
- (2020) Yantao Zhang et al. Cancer Cell International
- Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer
- (2019) Yi Zhang et al. MEDICINE
- Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery
- (2019) Hongcai Li et al. MEDICINE
- Pretreatment lymphocyte-to-monocyte ratio as a predictor of survival among patients with ovarian cancer: a meta-analysis
- (2019) Xu-ping Gao et al. Cancer Management and Research
- Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis
- (2019) Yi Zhang et al. Cancer Management and Research
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis
- (2019) Xingmu Wang et al. Frontiers in Oncology
- Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis
- (2019) Yan Wang et al. Annals of Translational Medicine
- Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysis
- (2019) Junkai Zhang et al. Future Oncology
- The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study
- (2019) Ali Yılmaz et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer
- (2018) Jing Guo et al. Cancer Management and Research
- Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex
- (2018) Ali Guner et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
- (2018) Ruonan Yang et al. Journal of Cancer
- Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients
- (2018) Hongtai Shi et al. DISEASE MARKERS
- Systemic immune-inflammation index for predicting prognosis of colorectal cancer
- (2017) Jian-Hui Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis
- (2017) Jie-Hui Zhong et al. Oncotarget
- Medical management of gastric cancer: a 2017 update
- (2017) Nikolaos Charalampakis et al. Cancer Medicine
- Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
- (2017) Li Chen et al. Cancer Management and Research
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection
- (2016) Liu Huang et al. Oncotarget
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The platelet–cancer loop
- (2013) Hadi A. Goubran et al. European Journal of Internal Medicine
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started